Summary T2 Biosystems, Inc. (T2 Biosystems) is a medical device company that develops clinical diagnostic products in the field of in vitro diagnostics. The company's T2 magnetic resonance technology allows direct detection in complex samples, such as whole blood, serum, plasma, sputum and urine. It offers T2 magnetic resonance instruments, including T2Candida, T2Lyme Panel, T2Bacteria, and T2Hemostatis. T2 Biosystems' T2MR detection technology is a biosensor technology, that provides rapid diagnostic results with minimal and no sample preparation. The company's T2Candida product provides species-specific identification directly from whole blood. It provides hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians' offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company T2 Biosystems, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 T2 Biosystems, Inc. Company Snapshot 6 T2 Biosystems, Inc. Company Overview 6 T2 Biosystems, Inc. Pipeline Products and Clinical Trials Overview 7 T2 Biosystems, Inc.- Pipeline Analysis Overview 9 Key Facts 9 T2 Biosystems, Inc. - Major Products and Services 10 T2 Biosystems, Inc. Pipeline Products by Development Stage 11 T2 Biosystems, Inc. Pipeline Products Overview 13 T2Bacteria 13 T2Bacteria Product Overview 13 T2Dx - Cancer 14 T2Dx - Cancer Product Overview 14 T2Dx - Cardiac 15 T2Dx - Cardiac Product Overview 15 T2Endotoxin 16 T2Endotoxin Product Overview 16 T2HemoStat 17 T2HemoStat Product Overview 17 T2Plex 18 T2Plex Product Overview 18 T2 Biosystems, Inc. - Key Competitors 19 T2 Biosystems, Inc. - Key Employees 20 T2 Biosystems, Inc. - Locations And Subsidiaries 21 Head Office 21 Other Locations & Subsidiaries 21 Recent Developments 22 T2 Biosystems, Inc., Recent Developments 22 Jun 02, 2016: Study Published in the American Journal of Clinical Pathology Demonstrates T2Candida Panel Provides Rapid and Accurate Diagnosis of Candida, a Leading Cause of Sepsis, in Pediatric Patients 22 May 02, 2016: T2 Biosystems Reports 2016 First Quarter Results 22 Apr 11, 2016: T2 Biosystems Announces Preliminary 2016 First Quarter Financial Results 23 Feb 16, 2016: T2 Biosystems Reports 2015 Fourth Quarter, Full Year Results 24 Nov 04, 2015: Study Results Demonstrate T2Bacteria Panel Achieves Rapid and Sensitive Detection of Six Clinically-Relevant Bacteria Species Directly From Whole Blood 26 Nov 03, 2015: T2 Biosystems Appoints Chief Commercial Officer 27 Nov 02, 2015: T2 Biosystems Reports 2015 Third Quarter Results 27 Oct 29, 2015: T2 Biosystems Announces Leading Hospitals Adopting T2Candida for Sepsis Detection 28 Oct 28, 2015: T2 Biosystems' T2Candida Panel Named Best Medical Technology Product at Prix Galien USA Awards 28 Sep 19, 2015: Study Demonstrates T2Candida Panel is More Sensitive and Rapid Than Blood Culture at Identifying Invasive Infections 29 Appendix 30 Methodology 30 About GlobalData 30 Contact Us 30 Disclaimer 30
List of Tables
T2 Biosystems, Inc. Pipeline Products and Clinical Trials Overview 7 T2 Biosystems, Inc. Pipeline Products by Equipment Type 7 T2 Biosystems, Inc. Pipeline Products by Indication 8 T2 Biosystems, Inc., Key Facts 9 T2 Biosystems, Inc., Major Products and Services 10 T2 Biosystems, Inc. Number of Pipeline Products by Development Stage 11 T2 Biosystems, Inc. Pipeline Products Summary by Development Stage 12 T2Bacteria - Product Status 13 T2Bacteria - Product Description 13 T2Dx - Cancer - Product Status 14 T2Dx - Cancer - Product Description 14 T2Dx - Cardiac - Product Status 15 T2Dx - Cardiac - Product Description 15 T2Endotoxin - Product Status 16 T2Endotoxin - Product Description 16 T2HemoStat - Product Status 17 T2HemoStat - Product Description 17 T2Plex - Product Status 18 T2Plex - Product Description 18 T2 Biosystems, Inc., Key Employees 20 T2 Biosystems, Inc., Other Locations 21
List of Figures
T2 Biosystems, Inc. Pipeline Products by Equipment Type 8 T2 Biosystems, Inc. Pipeline Products by Development Stage 11
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growiRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.